Public Company News
SK Biopharmaceuticals Launches Joint Venture with Eurofarma for AI-based Epilepsy Management Platform
SK Biopharmaceuticals forms a joint venture, Mentis Care, to develop an integrated epilepsy care ecosystem through AI-driven platform commercialization. SEOUL, South Korea, Oct. 20, 2025 /PRNewswire/ -- SK Biopharmaceuticals, Co., Ltd., a biotech company focusing on research, development, and co...
2025-10-21 09:20
1439
Eason Technology Limited Received NYSE American Non-Compliance Letter
HONG KONG, Oct. 20, 2025 /PRNewswire/ -- Eason Technology Limited ("Eason
Technology" or the "Company") (NYSE:DXF
2025-10-21 04:59
2452
The Generation Essentials Group Reports on Half Year Performance with a ~160% Increase in Revenue
* TGE Achieved ~160% Increase in Revenue * Hospitality arm's revenue increased by over 60% * Total Net Income Surged over 70% to US$61.0 million (non-GAAP adjusted) * Total Assets amounted to US$1.25 billion (US$25.7/share) * Net asset value amounted to US$841 million (US$17.3/share) PARIS...
2025-10-20 20:45
2344
HanchorBio Showcases Pipeline Momentum with HCB101 and HCB301 Data Across Five Major Oncology Meetings in Q4 2025
Presentations highlight HCB101's differentiated profile and introduce first preclinical data from HCB301, underscoring HanchorBio's innovation in next-generation immunotherapies TAIPEI, SHANGHAI and SAN FRANCISCO, Oct. 20, 2025 /PRNewswire/ -- HanchorBio Inc. (TPEx: 7827), a global clinical-stag...
2025-10-20 19:00
1671
HD Hyundai Vice Chairman Chung Kisun Promoted to Chairman
SEOUL, South Korea, Oct. 20, 2025 /PRNewswire/ -- HD Hyundai announced that
Executive Vice ChairmanChung Kisun has been promoted to Chairman in its latest
executive appointments.
2025-10-20 14:24
1922
Zeekr Group to Report Third Quarter 2025 Financial Results on November 17, 2025
HANGZHOU, China, Oct. 20, 2025 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("Zeekr Group" or the "Company") (NYSE: ZK), the world's leading premium new energy vehicle group, today announced that it will report its unaudited financial results for the third quarter endedSeptember 3...
2025-10-20 13:00
1723
CARsgen Presents Preliminary Results on Satri-cel for Adjuvant Therapy of Pancreatic Cancer at ESMO Congress 2025
SHANGHAI, Oct. 20, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the research results of the Phase Ib registrational clinical trial of satricabtagene autoleucel ("satri-cel", CT041)...
2025-10-20 08:15
2530
ESMO 2025: CStone Discloses Phase I Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody)
SUZHOU, China, Oct. 19, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone," HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, autoimmune/inflammation, and other key disease areas, today announced the first disclosure...
2025-10-20 08:10
1788
Clover Appoints Nicholas Jackson, Ph.D., as President of Global R&D and Alliances
SHANGHAI, Oct. 19, 2025 /PRNewswire/ -- Clover Biopharmaceuticals, Ltd.
2025-10-20 07:00
1401
Significant OS Benefit with Cadonilimab in First-Line Advanced Gastric Cancer: Final Analysis of COMPASSION-15 Presented at ESMO 2025
HONG KONG, Oct. 19, 2025 /PRNewswire/ -- On October 19, 2025, Akeso (9926.HK) announced the final analysis results from the COMPASSION-15/AK104-302 study at the 2025 European Society of Medical Oncology Congress (ESMO 2025) . COMPASSION-15 is a Phase III clinical trial evaluating cadonilimab, Ak...
2025-10-19 23:42
1819
HARMONi-6 Data: mPFS 11.14 Months (HR=0.6, P<0.0001) Simultaneously Released at ESMO and in The Lancet
* Ivonescimab plus chemotherapy demonstrated a median PFS of 11.14 months, PFS HR=0.60, P < 0.0001. * The absolute difference in median PFS between the two groups was 4.24 months (ΔPFS = 4.24 months), indicating significantly prolonged progression-free survival with ivonescimab combination th...
2025-10-19 23:37
1642
Case Report | Preliminary Clinical Data of CARsgen's Allogeneic BCMA CAR-T Product CT0596 for the Treatment of Primary Plasma Cell Leukemia
SHANGHAI, Oct. 19, 2025 /PRNewswire/ -- Primary plasma cell leukemia (pPCL) is a rare and highly aggressive plasma cell malignancy, often associated with complex genetic abnormalities. There is currently no standard treatment regimens, and conventional therapies for multiple myeloma are typically...
2025-10-19 14:00
1954
PINTEC's Subsidiary ZIITECH Makes Its Debut at Tech Week Singapore 2025
BEIJING, Oct. 17, 2025 /PRNewswire/ -- Pintec Technology Holdings Limited (Nasdaq: PT) ("PINTEC" or the "Company"), a leading technology platform committed to enabling innovative financial and digital solutions for businesses worldwide, today announced that its subsidiary ZIITECH PTY LTD ("ZIITEC...
2025-10-18 04:05
3550
CLPS Incorporation Reports Financial Results for the Second Half and Full Year of Fiscal 2025
HONG KONG, Oct. 17, 2025 /PRNewswire/ -- CLPS Incorporation (the "Company" or "CLPS") (Nasdaq: CLPS), today announced its financial results for the six months and full year of fiscal 2025 ended June 30, 2025. During this fiscal year, we faced a significant challenge when our long-standing and hi...
2025-10-17 21:23
4284
SparkRWA Expands AI Applications to Empower the Global Green Economy and Drive Sustainable Innovation
HONG KONG, Oct. 17, 2025 /PRNewswire/ -- GIBO Holdings Ltd. (NASDAQ: GIBO), Asia's leading innovation-driven creative ecosystem, today announced an extended application of its proprietary AI technologies under theSparkRWA Green Creator Framework, marking a major step toward integrating artificial...
2025-10-17 20:43
2418
Re-imagining Neo-Pragmatic Lifestyle: EPWK Launches Strategic Upgrade with "EPWK Curated Goods"
XIAMEN, China, Oct. 17, 2025 /PRNewswire/ -- "We grew weary of life's monotony, so we embarked on a journey to find 'EPWK Curated Goods.' Each selected item must pass our stringent 'Three Goods' standard: Good-looking, Good-to-use, and Good-surprise. We believe that truly excellent products can i...
2025-10-17 20:36
1624
Erayak Power Solution Group Inc. Establishes U.S. Subsidiary to Advance Global Expansion and Reinforce Long-Term Growth Strategy
WENZHOU, China, Oct. 17, 2025 /PRNewswire/ -- Erayak Power Solution Group Inc. ("Erayak" or the "Company") (Nasdaq: RAYA), a leading manufacturer and exporter of advanced power solution products, today announced the establishment of its U.S. subsidiary, Nexora Group Inc., marking a strategic mile...
2025-10-17 18:16
2504
SEMIFIVE Submits Securities Registration for KOSDAQ Listing
* Secures Only 'One-Stop AI ASIC Solution' in Korea and Big-Die Design Capability * 2025 Q3 Cumulative Revenue Expected to Surpass KRW 90 Billion; Large AI Chip Mass Production Begins, Growth to Accelerate from Q4 * Wins Successive AI Chip Design Projects for Global Customers, Expanding int...
2025-10-17 17:25
1948
NEW ORIENTAL EDUCATION & TECHNOLOGY GROUP INC. TO HOLD ANNUAL GENERAL MEETING ON NOVEMBER 21, 2025
BEIJING, Oct. 17, 2025 /PRNewswire/ -- New Oriental Education & Technology Group Inc. (the "Company" or "New Oriental") (NYSE: EDU and SEHK: 9901), a provider of private educational services inChina, today announced that it will hold an annual general meeting (the "AGM") of shareholders (the "Not...
2025-10-17 17:00
1851
FDA approves expanded pediatric indications for YUFLYMA® (adalimumab-aaty) and unbranded adalimumab-aaty in the United States
* YUFLYMA® (adalimumab-aaty), and its unbranded version, are now approved for two additional pediatric indications – adolescent hidradenitis suppurativa (HS) and pediatric uveitis (UV), in the U.S.[1],[2] * Pediatric UV is a rare eye inflammation in children, representing 5–10% of all uveitis...
2025-10-17 13:32
2609
Week's Top Stories
Most Reposted
HBX Group and Traveloka expand strategic partnership to deepen APAC supply and accelerate global distribution
[Picked up by 310 media titles]
2026-02-26 09:30
Amadeus acquires SkyLink to accelerate the deployment of AI in travel
[Picked up by 308 media titles]
2026-02-26 19:57
Visa partners with Laufey to spread the magic of travel in Asia Pacific; to be Official Payment Partner for Laufey: A Matter of Time Tour
[Picked up by 307 media titles]
2026-03-04 12:35
SMU and Fudan Launch Region's First Tech-Focused DBA
[Picked up by 300 media titles]
2026-03-02 09:15Infobip is set to launch AgentOS to orchestrate autonomous AI-driven customer journeys at scale
[Picked up by 289 media titles]
2026-03-02 09:00
Most Read
COLUMBIA ASIA HOSPITAL BUKIT JALIL LAUNCHES NEW CATH LAB TO STRENGTHEN HEART CARE SERVICES
2026-03-02 14:24
8809
